Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.35 - $1.07 $887,423 - $2.71 Million
2,535,495 Added 102.88%
5,000,000 $1.75 Million
Q1 2024

May 15, 2024

BUY
$0.64 - $1.13 $1.58 Million - $2.78 Million
2,464,505 New
2,464,505 $2.42 Million
Q1 2023

May 15, 2023

SELL
$0.87 - $2.11 $217,500 - $527,500
-250,000 Reduced 16.97%
1,223,278 $1.06 Million
Q1 2022

May 16, 2022

BUY
$2.08 - $12.2 $3.06 Million - $18 Million
1,473,278 New
1,473,278 $3.17 Million

Others Institutions Holding ALGS

# of Institutions
1
Shares Held
227K
Call Options Held
0
Put Options Held
0

About Aligos Therapeutics, Inc.


  • Ticker ALGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,717,000
  • Market Cap $1.57B
  • Description
  • Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...
More about ALGS
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.